Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Examining the Long-term Safety of Insulin Aspart When Used as a Part of the Treatment for Type 1 Diabetes

This study has been completed.
Information provided by:
Novo Nordisk A/S Identifier:
First received: January 29, 2009
Last updated: June 8, 2012
Last verified: September 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2002
  Primary Completion Date: November 2002 (Final data collection date for primary outcome measure)